SEATTLE, June 15, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Global Malaria Vaccine Market is estimated to be valued at US$ 41.08 million in 2022 and is expected to exhibit a CAGR of 29.6% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Basal cell carcinoma Market:
Key trends in market include increasing fund raising activities to support malaria vaccine are expected to drive market growth over the forecast period. For instance, In December 2021, The Board of Gavi, the vaccine alliance approved an investment to support the malaria vaccine introduction, procurement and delivery for Gavi-eligible countries in sub-Saharan Africa in 2022-2025. An initial investment of US$ 155.7 million for 2022-2025 will initiate the implementation of this additional tool in the combat against malaria.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/37
Key Market Takeaways:
Global malaria vaccine market is expected to exhibit a CAGR of 29.6% during the forecast period due to increasing burden of malaria which is expected to drive the global malaria vaccine market growth over the forecast period. For instance, According to World Health Organization’s World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide in 2020.
Among Agent, Plasmodium Falciparum segment is estimated to hold a dominant position in the global malaria vaccine market in 2022, owing to high prevalence of Plasmodium falciparum malaria, which is expected to drive market growth over the forecast period. For instance, according to data published by National Center for Biotechnology Information in August 2021, Infection with Plasmodium Falciparum is being accounted for more than 90% of the world’s malaria mortality and therefore remains an important threat to public health on a global scale.
On the basis of vaccine type, Pre-Erythrocytic is estimated to hold a dominant position in the global malaria vaccine market over the forecast period due to increase in launch of malaria vaccine. For instance, in October 2021, GlaxoSmithKline is a science-led global healthcare company, announced that the company’s RTS,S, is a vaccine that acts against Plasmodium falciparum, the deadliest malaria parasite globally and the most prevalent in Africa, can now be made available to children in sub-Saharan Africa and other regions with moderate to high malaria transmission.
Competitive Landscape:
Key players operating in the Global Malaria Vaccine Market are GlaxoSmithKline, Nobelpharma, Sanaria, CellFree Sciences, VLP Therapeutics LLC, Sumaya Biotech, BioNTech, and Precigen, Inc
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/37
Market segmentation:
- Global Malaria vaccine Market, By Agent :
- Plasmodium Falciparum
- Plasmodium Vivax
- Anopheles Species
- Global Malaria vaccine Market, By Vaccine Type :
- Pre-Erythrocytic
- Erythrocytic
- Multi-antigen
- Global Malaria vaccine Market, By Distribution Channel :
- Public
- Private
- Global Malaria vaccine Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- By Country
- North America
Related Market Intelligence Reports:
Pyrimethamine Market, by Indication (Toxoplasmosis, Malaria, and Others), by Route of Administration (Parenteral and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Anti-malarial Drugs Market, by Drug Class (Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and Sulfones, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
